InvestorsHub Logo
Followers 3177
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: mopar44o post# 12969

Thursday, 08/27/2015 12:28:26 PM

Thursday, August 27, 2015 12:28:26 PM

Post# of 38634
Yes it's confirmed that there's going to be 2 versions of Rexista...the 1st one which has already been fast tracked is the original potential best-in-class version incorporating their npodds tech...which IPCI is currently doing the bioequivalence on for submission to the FDA most likely during Q1 2016 which will be the 7 to 9 month mark from when they received the go ahead from the FDA to skip phase III entirely.

But they're also working simultaneously on an enhanced version of Rexista which will incorporate their PODRAS tech...but obviously due to what PODRAS can do ie: stop over-doses...the enhanced version of Rexista incorporating the PODRAS tech is going to require a lot of clinical trials and human abuse testing still...so we'll be hearing a lot more about the enhanced version of Rexista incorporating PODRAS after the PODRAS patent gets granted soon k!

Make no mistake about it though...Domenic was adamant that the potential best-in-class designation on Rexista incorporating npodds is still their expectation ok! The Rexista version incorporating PODRAS will simply be an enhanced improvement on their already best-in-class Rexista designation k cheers~

Love the trend not the stock - If you fail to plan your trades you plan to fail

My posts are just my own opinion!